Treatment signals for vascular cognitive impairment remain uncertain
A broad review reported cognitive and functional improvements with some approaches, but low certainty limits what those results mean for patients.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This review asked whether treatments already studied for vascular cognitive impairment deserve another look. Several approaches showed improvements in cognition, and Ginkgo biloba extracts also showed improvements in functional outcomes. However, the evidence was generally uncertain, and the abstract does not establish which approach offers a meaningful benefit for a particular patient.
Few interventions had been repeatedly tested in studies of adequate size and design. The abstract also leaves treatment comparators and follow-up periods unspecified, limiting interpretation of the reported effects.
A broad evidence base
Researchers reviewed 173 trials covering 91 interventions and 145 outcomes. The range of treatments and measures made this a broad survey, while substantial differences between studies limited how firmly the pooled results could be interpreted.
Clinical meaning remains unclear
Cognitive improvements were reported for several medicines, physical exercise and cognitive rehabilitation. Ginkgo extracts showed a signal across cognition and function, but the authors described its clinical significance as uncertain and overall evidence certainty as low.
The original publication
Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis.
Masserini F, Gendarini C, Baso G et al.
Alzheimers Dement · 2025
- PubMed ID
- 41198594
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.